Eu Construction Products Regulation Consultant
An EU Construction Products Regulation (CPR) consultant should settle the product's intended use, the legally applicable technical route and the missing evidence before ordering tests or preparing a CE-marking dossier. This advice concerns EU market placement, not approval of a product for a particular building project: national building rules still determine suitability for a given use.
Choose the route from the product and the Official Journal citation
Start with the exact product or kit, its components, declared intended use and the applicable cited standard or assessment document. A catalogue category or an uncited EN standard is not sufficient to establish a CPR CE-marking obligation. Use the matrix as a decision screen, not a product-specific legal conclusion.
| Product situation | Strategic route | Fact that could change the decision |
|---|---|---|
| Intended use is covered by a harmonised standard cited under CPR 305/2011 | Assess under the applicable 2011 CPR route while its citation and transitional provisions remain applicable; check the relevant AVCP system. | Check the cited standard's scope, dates and any replacement under CPR 2024/3110. |
| Product family is subject to an applicable new performance harmonised specification under CPR 2024/3110 | Use the new CPR route, its assessment and verification system (AVS), and the declaration of performance and conformity (DoPC) requirements as applicable. | Confirm the new specification's application date, product scope and transition arrangements. |
| No applicable harmonised performance standard; product is eligible for an EAD/ETA route | Consider voluntary European Technical Assessment (ETA) through a competent Technical Assessment Body (TAB); check that the relevant EAD is cited before relying on an ETA for CPR CE marking. | Verify whether any mandatory specification covers the intended use and whether the EAD/ETA is usable under the relevant transition rules. |
| No applicable cited standard or usable ETA route | Do not invent a CPR CE mark. Map applicable national non-harmonised rules and any other EU regimes; examine mutual recognition only if its legal prerequisites are met. | Identify destination states, evidence of lawful marketing elsewhere and other product-specific obligations. |
The decisive reference is an applicable publication in the Official Journal of the EU and the legal conditions attached to it—not simply the existence of an EN number, a laboratory report or an old certificate.
Two CPR frameworks coexist: check the product family's transition
Regulation (EU) 2024/3110 generally applies from 8 January 2026, subject to provisions with different dates. That date does not automatically migrate every construction product to the new declaration or assessment system. CPR 305/2011 continues to govern relevant product families during the transition; its remaining provisions are scheduled for repeal from 8 January 2040.
For each product, record the cited reference and its version, the relevant date of application or withdrawal, the applicable assessment system, and whether an existing ETA/EAD is still usable. Do not treat the new digital product passport as universally mandatory now: its operative obligations depend on further implementing measures and relevant triggers.
Evidence-reuse and gap matrix before paying for new work
Existing test reports, factory production control records and certificates are inputs, not automatic proof for a different formulation, factory, intended use or regulatory route. Compare each file with the selected specification and the manufacturer's actual supply chain.
| Existing item | Verify | Decision or gap |
|---|---|---|
| Old laboratory report | Method, measured characteristics, sample identity, accreditation or notified-body scope where required, and changes in specification. | Reuse only where technical and legal equivalence is documented; otherwise plan targeted reassessment. |
| Factory production control (FPC) material | Factory site, process controls, product-family boundaries and the allocated AVCP/AVS tasks. | Map missing controls and third-party involvement; a report from another site alone cannot close the gap. |
| Prior DoP, CE label or ETA | Correct legal framework, product variant, intended use, current OJ reference and document validity/transition conditions. | Retain matching evidence; revise the route and declaration if its legal basis or product scope changed. |
| Supplier and environmental information | Traceability, constituent changes, data rights and whether verified environmental characteristics are required for this route. | Request missing upstream data; do not claim environmental performance without a supported method. |
Four decision gates for a defensible compliance strategy
Use these gates in order. A failing gate is a reason to stop spending on execution, clarify facts or commission a narrowly defined assessment—not a reason to assume non-compliance.
- Freeze a product identity sheet: model or kit, intended use, material composition, manufacturing sites, variants and target EU countries.
- Search current EU Official Journal citations and check exact scope, dates, applicable CPR generation and alternative ETA eligibility; keep a dated route memo.
- Compare existing evidence to the required characteristics, assessment system and economic-operator duties; flag only verifiable gaps and assign an owner to each.
- Approve a written next-action decision: reuse, supplementary tests, TAB consultation, documentation work or a national-rule review, with change triggers for revised products or standards.
Who remains responsible, and what this advice does not certify
The manufacturer remains responsible for the appropriate declaration and technical documentation; importers and distributors have their own duties. Notified-body or TAB involvement depends on the identified route, not on a consultant's preference. A consultant cannot issue an ETA or substitute for a designated body merely by calling an opinion a certificate.
CPR CE marking concerns declared product performance and applicable conformity duties; it is not an EU-wide building-permit approval or a guarantee of suitability in every Member State. Other EU legislation may apply independently, and marketing into a different country can require checking local building-use rules and document-language obligations.
Common questions before choosing a CPR consultant
Does every construction product need a CPR CE mark?
No. The answer depends on an applicable cited harmonised technical specification or a usable ETA route. A product outside those routes may still face national rules and other EU legislation; do not affix a CPR CE mark without a proper legal basis.
Is an existing EN test report enough for CE marking?
Not by itself. First establish the cited product specification, the covered intended use, the current AVCP/AVS tasks and traceability. Reuse is a justified evidence decision, not an automatic entitlement.
Must all products switch to CPR 2024 documents in 2026?
No. The frameworks coexist during a staged transition. Determine the applicable product-family specification and its transition dates before deciding between a DoP and a DoPC.
Can an innovative kit use an ETA if a harmonised standard exists?
Only if the legal conditions for the ETA/EAD route are satisfied, including the intended-use and non-overlap rules. A competent TAB should assess an uncertain boundary before any investment in an EAD.
Can one CE mark confirm acceptance for every construction project?
No. It supports marketing under applicable harmonised rules; national requirements for use in a particular building and the declared performance required by the designer remain separate questions.
Official legal and technical starting points
Use the current official texts and product-family citations; source links are starting points, not evidence that a particular product has been classified.
What to send for an initial route assessment
Provide the datasheet, intended-use statement, drawings or kit composition, manufacturing locations, previous DoP/ETA, reports and certificates, any assumed EN/EAD reference, and target EU markets. The useful output is a dated route-and-gap memorandum with unresolved questions and a prioritised next decision; detailed laboratory work and CE-marking execution belong to separate service scopes.
Testing and evidence services · CPR CE-marking execution services